Kyverna Therapeutics, Inc. (KYTX) vs PureTech Health PLC Sponsored ADR (PRTCY)

Kyverna Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Kyverna Therapeutics, Inc. and PureTech Health PLC Sponsored ADR are of similar size ($432.3M and $424.0M). Kyverna Therapeutics, Inc. has the higher net margin (0.00% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, PureTech Health PLC Sponsored ADR leads on 5 and Kyverna Therapeutics, Inc. on 4.

Valuation

Metric KYTX PRTCY Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.51 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.78 0.74
EV/Sales n/m (8.76) 10.73
Earnings yield (43.17%) (1.40%) (28.84%)
Free cash flow yield (38.34%) 0.00% (23.03%)

Profitability

Metric KYTX PRTCY Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (199.36%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (87.24%) 0.00% (57.72%)
Return on assets (68.40%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYTX PRTCY Biotechnology median
Revenue growth (TTM) — 28.48% 5.64%
EPS growth (last fiscal year) (9.31%) (2,277.05%) —
Revenue growth, 5-year CAGR — (23.16%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KYTX PRTCY Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 9.06 6.59 4.73
Net debt to EBITDA 1.51 3.03 0.96

Dividend

Metric KYTX PRTCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric KYTX PRTCY Biotechnology median
Market cap 432.29m 424.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack